As Chinese government gradually liberalizes the restrictions on foreign investment, it encourages foreign investment in hospitals and medical facilities. Meanwhile, in order to meet the needs of domestic chronic disease treatment and population aging, Chinese enterprises have acquired and invested in overseas enterprises to acquire high-tech and high-end brand value. To get international cooperation and face competition became the hot topic in the medical industry in 2017.
International Bio & Healthcare Fortune Forum M&A Conference of Hengqin 2017 is based on the Hengqin Free Trade Zone, with speakers from worldwide investment institutions, healthcare enterprises, government officials and industry associations. The forum focused on the topic of "the medical industry trend of capital and technology globalization”, having an in-depth interpretation of the latest medical and health industry policy in China. At the same time, the coming visitors had an in-depth study of the global capital and medical technology, the integration and development of talented person, the industry's investment trends and hot issues. Through analyzing the current domestic healthcare industry, more technical problems and solutions for international capital market have been raised, encouraging the domestic and overseas enterprises to have better communication and advanced cooperation in the investment trends.